KLH conjugated synthetic peptide selected from the C terminal region of human TRIP.
Our Abpromise guarantee covers the use of ab80170 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
|WB||1/50 - 1/100. Predicted molecular weight: 53 kDa.|
ab80170 has not yet been referenced specifically in any publications.